Skip to content
Choksi Laboratories logo

Choksi Laboratories

526546 BSE
₹203.90

Close ·

P/E
65.77
View as Markdown
MCP
Close 4 Nov 2026 ₹203.90 +61.40 +43.1% 1Y
Start ₹142.50

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
9.44%
Debt to Equity
1.34
EPS (TTM)
₹3.10
Book Value
₹36.72
Market Cap
—
P/E (TTM)
65.77
P/B
5.55
ROE
4.19%
Dividend Yield
0.00%
EBITDA
₹12.30 Cr
52W High
₹227.90
52W Low
₹81.85

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

54 Average

Data confidence 100/100

Category scores

Quality
64
Good
Returns, margins, earnings quality 22% weight
Valuation
35
Poor
Cheap vs sector & own history 24% weight
Growth
53
Average
Sales & profit trajectory 9% weight
Financial Health
25
Poor
Solvency, leverage, coverage 9% weight
Momentum
99
Strong
Trend strength, vol-adjusted 12% weight
Ownership
56
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

5
  • Stock is trading at 5.03 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 31.5%
  • Company has a low return on equity of 5.29% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish3610
OscillatorsBullish162
Moving AveragesStrong Bullish208

Key readings

RSI (14)
53.29
Neutral
MACD (12,26,9)
4.46
Bearish
SMA (50)
187.48
Bullish
SMA (200)
131.40
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+6.25%
5Y+12.36%
3Y+10.14%
1Y+10.12%
TTM+10.74%

Net profit

Net profit growth by window
10Y+10.53%
5YTurned to profit
3Y−15.16%
1Y+28.95%
TTM+44.00%

Operating cash flow

Operating cash flow growth by window
10Y+94.78%
5Y+5.90%
3Y−1.60%
1Y−33.28%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+5.95 pp
5Y+10.43 pp
3Y−3.35 pp
1Y−0.58 pp
TTM−0.01 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹28.63 Cr
Mar 2018₹30.40 Cr
Mar 2019₹33.74 Cr
Mar 2020₹28.16 Cr
Mar 2021₹25.69 Cr
Mar 2022₹30.04 Cr
Mar 2023₹34.44 Cr
Mar 2024₹36.70 Cr
Mar 2025₹41.78 Cr
Mar 2026₹46.01 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.89 Cr
Mar 2018₹1.35 Cr
Mar 2019₹1.60 Cr
Mar 2020−₹3.88 Cr
Mar 2021−₹2.61 Cr
Mar 2022₹0.21 Cr
Mar 2023₹3.21 Cr
Mar 2024₹1.11 Cr
Mar 2025₹1.52 Cr
Mar 2026₹1.96 Cr

Quarterly Results

₹ Cr
526546 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
8.88
7.95
8.79
11.12
10.74
9.26
10.38
11.4
11.24
11.12
10.82
12.82
12.06
Expenses
6.45
5.84
6.55
7.63
7.91
6.9
7.84
7.9
8.34
8.19
8.16
9.18
8.78
Operating Profit
2.43
2.11
2.24
3.49
2.83
2.36
2.54
3.5
2.9
2.93
2.66
3.64
3.28
OPM %
27.36%
26.54%
25.48%
31.38%
26.35%
25.49%
24.47%
30.7%
25.8%
26.35%
24.58%
28.39%
27.2%
Other Income
0
0.05
0
0.06
0.01
0.01
0.01
0.04
0
0.01
0.89
0.06
0.02
Interest
0.82
0.74
0.67
0.77
0.72
0.66
0.69
0.58
0.6
0.69
0.81
0.71
0.73
Depreciation
1.39
1.41
1.43
1.49
1.5
1.61
1.68
1.7
1.68
1.69
1.83
1.89
1.97
PBT
0.22
0.01
0.14
1.29
0.62
0.1
0.18
1.26
0.62
0.56
0.91
1.1
0.6
Tax %
−59.09%
0%
57.14%
46.51%
30.65%
20%
44.44%
26.98%
38.71%
57.14%
64.84%
6.36%
3.33%
Net Profit
0.36
0.01
0.06
0.68
0.42
0.08
0.11
0.92
0.39
0.24
0.31
1.03
0.58
EPS (₹)
0.52
0.01
0.09
0.98
0.6
0.11
0.16
1.32
0.56
0.34
0.45
1.48
0.83

Profit & Loss

₹ Cr
526546 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
24.45
25.1
28.63
30.4
33.74
28.16
25.69
30.04
34.44
36.7
41.78
46.01
46.82
Expenses
19.3
19.95
23.85
24.06
26.48
24.62
21.57
21.14
24.17
26.42
30.48
33.83
34.31
Operating Profit
5.15
5.15
4.78
6.34
7.26
3.54
4.12
8.9
10.27
10.28
11.3
12.18
12.51
OPM %
21.06%
20.52%
16.7%
20.86%
21.52%
12.57%
16.04%
29.63%
29.82%
28.01%
27.05%
26.47%
26.72%
Other Income
0.63
−0.05
0.86
0.35
0.25
−2.8
0.49
0.12
2.47
0.16
0.07
0.96
0.98
Interest
1.57
1.23
1.47
1.59
1.54
1.89
2.82
3.23
3.52
3.06
2.72
2.86
2.94
Depreciation
2.83
2.73
2.86
3.16
3.68
4.56
4.6
5.43
5.5
5.71
6.5
7.09
7.38
PBT
1.38
1.14
1.31
1.94
2.29
−5.71
−2.81
0.36
3.72
1.67
2.15
3.19
3.17
Tax %
36.23%
36.84%
32.06%
29.9%
30.13%
−32.05%
−7.12%
44.44%
13.71%
32.93%
29.3%
38.56%
—
Net Profit
0.88
0.72
0.89
1.35
1.6
−3.88
−2.61
0.21
3.21
1.11
1.52
1.96
2.16
EPS (₹)
1.26
1.03
1.28
1.94
2.3
−5.57
−3.75
0.3
4.61
1.59
2.18
2.81
3.1
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
526546 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
6.97
Reserves
12.35
13.07
14.16
15.43
17.04
13.26
10.78
10.94
14.14
15.25
16.64
18.61
Borrowings
11.65
13.68
11.2
12.43
17.05
31.64
39.15
37.29
32.41
30.87
29.15
34.17
Other Liabilities
6.7
8.81
8.32
9.85
14.28
13.14
9.48
9.22
6.84
8.86
12.57
12.17
Total Liabilities
37.67
42.53
40.65
44.68
55.34
65.01
66.38
64.42
60.36
61.95
65.33
71.92
Fixed Assets
19.28
17.64
22.23
28.62
34.81
33.08
50.32
46.56
44.83
43.43
47.61
51.55
CWIP
2.73
8.99
4.28
0
3.23
13.06
0.5
1.67
0.31
2.99
0
0.4
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
15.66
15.9
14.14
16.06
17.3
18.87
15.56
16.19
15.22
15.53
17.72
19.97
Total Assets
37.67
42.53
40.65
44.68
55.34
65.01
66.38
64.42
60.36
61.95
65.33
71.92

Cash Flow

₹ Cr
526546 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2.3
0.01
6.57
6.25
6.91
2.87
5.9
7.88
8.25
11.55
11.78
7.86
Investing
−0.73
−0.01
−1.88
−4.92
−9.76
−13.76
−7.65
−2.71
−0.71
−6.65
−7.61
−7.07
Financing
−1.37
0
−4.89
−0.94
2.13
11.09
1.63
−5.07
−7.61
−4.58
−4.22
−1.2
Net Cash Flow
0.21
0
−0.2
0.39
−0.72
0.2
−0.12
0.1
−0.07
0.32
−0.04
−0.41
Free Cash Flow
1.4
0
4.18
1.3
−3.09
−11.18
−2.18
5.05
7.34
4.54
4.09
0.62
CFO/OP
53
0
124
124
137
111
68
75
73
117
122
69

Ratios

526546 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
126
125
112
119
95.09
90.6
116
125
113
103
98.46
117
Inventory Days
0
0
28.27
30.5
37.89
20.28
15.62
46.09
34.68
51.33
65.94
25.47
Days Payable
—
—
591
594
661
723
686
741
297
560
639
594
Cash Conversion Cycle
126
125
−451
−445
−528
−612
−554
−570
−150
−406
−475
−452
Working Capital Days
29.26
3.34
−23.71
−18.37
28.02
21.13
−49.73
−23.33
11.66
−49.13
−71.29
−35.14
ROCE %
7.94%
7.51%
7.33%
10.51%
10.09%
−1.48%
0%
6.4%
9.16%
8.87%
9.2%
9.44%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Choksi Laboratories insights

60 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Public 47.96%
  • Promoters 31.48%
  • Others 10.54%
  • FIIs 10.01%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Choksi Laboratories

What does Choksi Laboratories Ltd do?
Incorporated in 1982, Choksi Laboratories Ltd provides contract testing and analytical services.
Where is Choksi Laboratories Ltd (CHOKSILA) listed?
Choksi Laboratories Ltd trades under code 526546 on the BSE.
Which sector does Choksi Laboratories Ltd belong to?
Choksi Laboratories Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Choksi Laboratories Ltd?
Choksi Laboratories Ltd trades at a PE ratio of 65.77 as of 4 Nov 2026, on earnings per share of ₹3.1, against a book value of ₹36.72 per share.
What is the 52-week high and low of Choksi Laboratories Ltd?
Over the last 52 weeks Choksi Laboratories Ltd has traded between ₹81.85 and ₹227.9 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Choksi Laboratories Ltd?
Choksi Laboratories Ltd reported a return on equity of 4.19%. Its debt-to-equity ratio is 1.34.

Company Information

Incorporated in 1982, Choksi Laboratories Ltd provides contract testing and analytical services.

Website choksilab.com
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526546.md for Choksi Laboratories Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month